A randomised, double blind clinical trial was undertaken to compare a Ginkgo biloba standardised extract (GBSE) against donepezil in patients with confirmed Alzheimer’s disease (AD) also exhibiting neuropsychiatric symptoms. The true potential of this study is the suggestion that combining Ginkgo with donepezil might improve treatment outcomes and lower side
effects as the majority of patients given Ginkgo in the real world are already taking donepezil. To read more, Yancheva S, Ihl R, Nikolova G et al. Aging Ment Health 2009;
13(2): 183-190.
